Medical device company Nevro received FDA approval to use its Senza spinal cord stimulation system to treat nonsurgical refractory back pain, the company said Jan. 19.
Nevro's product is now the only spinal cord stimulation system labeled to treat the condition, the company said.
The FDA approval came after the company conducted a 12-month study into its system's treatment of back pain. The company said study participants saw improvements in pain relief, quality of life and a reduction in daily opioid use compared to conventional treatments.